Financial Calendar - Full-year results and Q4 2025 sales are scheduled for 25 March 2026, with a quiet period from 11 to 25 March 2026 [1] - Q1 2026 sales will be reported on 21 May 2026, with a quiet period from 7 May to 21 May 2026 [2] - The Annual General Meeting is set for 18 June 2026, and half-year results along with Q2 2026 sales will be released on 23 September 2026, with a quiet period from 9 to 23 September 2026 [3] - Q3 2026 sales are expected on 1 December 2026, with a quiet period from 17 November to 1 December 2026 [4] Company Overview - Quadient is a global automation platform that facilitates secure and sustainable business connections through both digital and physical channels [5] - The company supports businesses of all sizes in their digital transformation and growth journey, focusing on operational efficiency and enhancing customer experiences [5] - Quadient is listed in compartment B of Euronext Paris (QDT) and is part of the CAC Mid & Small and CAC Technology indices, making its shares eligible for PEA-PME investing [5]

Group 1 - Pluxee N.V. disclosed transactions on treasury shares for the period from January 12 to January 16, 2026 [1] - The total volume of shares acquired daily varied, with notable transactions on January 12, 13, 14, 15, and 16, 2026 [2] - The weighted average price of shares acquired showed a downward trend over the specified period, starting from €12.4396 on January 12 to €11.3665 on January 16 [2] Group 2 - Pluxee operates in 28 countries and specializes in Employee Benefits and Engagement, providing solutions across various sectors including Meal & Food, Well-being, and Reward & Recognition [3] - The company has over 5,600 engaged team members and serves more than 500,000 clients, impacting over 37 million consumers and 1.7 million merchants [3] - With over 45 years of experience, Pluxee is committed to creating a positive impact on local communities and supporting employee well-being [3]

The New York Stock Exchange (NYSE:ICE) announced today its intent to offer tokenized securities. The plan by the “big board” to move into digital asset securities is emblematic of the realization that eventually all securities will be digital.Tokenization, or digital securities, on the NYSE platform will offer 24/7 trading in traditional securities, newly issued tokens, and ETFs. It will also offer fractional share trading, a service that has become popular on more modern brokerages.Settlement will be immed ...

The Tel Aviv Stock Exchange fell today. The Tel Aviv 35 Index fell 0.08% to 3,968.81 points, the Tel Aviv 125 Index fell 0.85% to 3,987.85 points; and the BlueTech Global Index fell 0.10% to 698.43 points. The All Bond corporate bond index fell 0.21% to 422.79 points. Turnover totalled NIS 3.84 billion in equities and NIS 5.91 billion in bonds. On the foreign exchange market, the representative shekel-dollar rate was set 0.701% higher from Friday, at NIS 3.16/$, and the representative shekel-euro rate was ...

Core Insights - ImmunityBio's shares increased by 39.8% on Friday and an additional 9.4% in after-hours trading following the release of updated efficacy and safety data from the QUILT-106 clinical study [2][8] - The QUILT-106 study is assessing an allogeneic CD19 CAR-NK therapy in combination with Roche's Rituxan for patients with Waldenström non-Hodgkin's lymphoma, showing promising results [3][4] Study Results - Updated data from the QUILT-106 study indicate durable complete responses and sustained disease control in patients with Waldenström NHL, with 100% disease control observed to date and responses extending up to 15 months [4][8] - The treatment regimen involves off-the-shelf CD19 CAR-NK cells combined with Rituxan, administered in an outpatient setting without the need for chemotherapy-based lymphodepletion [5][9] - Four patients have been enrolled in the study, all of whom remain in clinical disease control, with two patients demonstrating durable complete remission at seven and 15 months, respectively [6][10] Market Performance - Over the past six months, ImmunityBio's shares have surged by 106%, significantly outperforming the industry average growth of 22.1% [7] Future Developments - Enrollment and follow-up in the QUILT-106 study are ongoing, with further clinical updates expected as more patients become evaluable [10] - A follow-up study is planned to evaluate the combination of NK-CAR with ImmunityBio's IL-15 superagonist, Anktiva, and Roche's Rituxan to enhance current results in indolent lymphoma [10] Additional Programs - ImmunityBio is making progress in its first-line BCG-naïve NMIBC program, with enrollment in the QUILT-2.005 study exceeding expectations, targeting full enrollment by Q2 2026 [12] - The QUILT-2.005 study is evaluating Anktiva in combination with BCG, showing statistically significant improvements in complete response duration compared to BCG alone [14]

Core Viewpoint - JCDecaux has been recognized for the third consecutive year in CDP's A List, affirming its leadership in environmental transparency and performance in combating climate change [1][2][9] Group Performance and Recognition - Among 20,000 companies assessed by CDP, JCDecaux ranks in the top 4% included in the A List, marking the fifth time the company has achieved this recognition since 2019 [2] - The assessment by CDP is based on a rigorous methodology that evaluates the quality and completeness of disclosed data, governance, and the management of climate-related risks and opportunities [3] Carbon Reduction Commitments - JCDecaux aims to achieve Net Zero Carbon by 2050, with a key milestone of reducing Scope 1 and 2 emissions by at least 73% and Scope 3 emissions by 46% by 2030 compared to 2019 [4][8] - In 2024, JCDecaux reported a 65% reduction in Scope 1 and 2 emissions and a 21% reduction in Scope 3 emissions compared to 2019 [8] Engagement and Collaboration - The company is actively engaging with stakeholders to co-develop responsible media solutions and lower-carbon street furniture, supporting sustainable urban environments [5] - JCDecaux's business model aligns with the European Union Taxonomy, with nearly 50% of its revenue reflecting sustainable practices [6] Key Figures - JCDecaux reported a revenue of €3,935.3 million in 2024 and €1,868.3 million in H1 2025, maintaining its position as the number one outdoor advertising company worldwide [13] - The company operates 1,091,811 advertising panels globally and has a daily audience of 850 million people across more than 80 countries [13]

Bitcoin briefly appeared to trade at zero on Paradex early Sunday after a technical failure during scheduled maintenance triggered mass liquidations across the decentralized perpetual futures exchange, forcing the team to announce a rare chain rollback to reverse the damage. The incident unfolded shortly after Paradex carried out database maintenance at around 4:30 a.m. London time. Within minutes, traders began reporting that prices on several perpetual markets, including Bitcoin, Ethereum, and Solana, ...

Artificial intelligence (AI) is broadly expected to turbocharge the pace of data center construction in 2026, with hyperscalers racing to meet soaring compute demand. And since data center buildout often raises power prices for local communities, the idea of on-site power generation may start to resonate with the AI titan this year. Against that backdrop, Bernstein senior analyst Chad Dillars argues Caterpillar Inc (NYSE: CAT) could emerge as the biggest corporate beneficiary in the months ahead. At the tim ...

Hong Kong’s crypto industry is warning that the city’s planned adoption of new global tax reporting rules could produce unintended consequences if regulators do not adjust how the framework is applied in practice. The concerns center on the Crypto-Asset Reporting Framework (CARF), a standard developed by the Organisation for Economic Co-operation and Development to enable the automatic cross-border exchange of tax information related to crypto-asset transactions. Hong Kong officials say the CARF is need ...

As the crypto market continues trading sideways, analysts argue that we may soon enter the last phase of this bull run, but also that we’ll likely see further downside. However, there are significant risk-off factors preventing a Bitcoin (BTC) recovery. The crypto market posted a notable increase last week, but dipped over the weekend and started this week lower. Looking at BTC, over the past 24 hours, it dropped from the intraday high of $95,467 to the low of $92,263. At the time of writing (Monday aft ...